Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 9
2004 3
2005 6
2006 8
2007 5
2008 10
2009 6
2010 9
2011 14
2012 12
2013 9
2014 6
2015 16
2016 10
2017 13
2018 10
2019 8
2020 12
2021 9
2022 6
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
Vose JM, Fu K, Wang L, Mansoor A, Stewart D, Cheng H, Smith L, Yuan J, Qureishi HN, Link BK, Cessna MH, Barr PM, Kahl BS, Mckinney MS, Khan N, Advani RH, Martin P, Goy AH, Phillips TJ, Mehta A, Kamdar M, Crump M, Pro B, Flowers CR, Jacobson CA, Smith SM, Stephens DM, Bachanova V, Jin Z, Wu S, Hernandez-Ilizaliturri F, Torka P, Anampa-Guzmán A, Kashef F, Li X, Sharma S, Greiner TC, Armitage JO, Lunning M, Weisenburger DD, Bociek RG, Iqbal J, Yu G, Bi C; North American Mantle Cell Lymphoma Consortium. Vose JM, et al. Among authors: crump m. J Hematol Oncol. 2023 Dec 16;16(1):122. doi: 10.1186/s13045-023-01520-7. J Hematol Oncol. 2023. PMID: 38104096 Free PMC article.
Very late relapse in Hodgkin lymphoma: Characterizing an understudied population.
Cherniawsky H, Ting E, Zhang JZ, Xu W, Prica A, Bhella S, Yang C, Kridel R, Vijenthira A, Kukreti V, Crump M, Kuruvilla J. Cherniawsky H, et al. Among authors: crump m. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):838-843. doi: 10.1016/j.clml.2023.07.012. Epub 2023 Jul 31. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37562990 Review.
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.
Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JCH, Cruz M, Roth A, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, Freeman CL, Villa D, Rodrigo JA, Song K, Crump M, Shepherd L, Hay AE, Kuruvilla J, Savage KJ, Kridel R, Karsan A, Marra MA, Sehn LH, Steidl C, Morin RD, Scott DW. Hilton LK, et al. Among authors: crump m. J Clin Oncol. 2023 Sep 1;41(25):4164-4177. doi: 10.1200/JCO.23.00570. Epub 2023 Jun 15. J Clin Oncol. 2023. PMID: 37319384
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
Gupta A, Hay AE, Crump M, Djurfeldt MS, Zhu L, Cheung MC, Shepherd LE, Chen BE, Booth CM. Gupta A, et al. Among authors: crump m. Oncologist. 2023 Sep 7;28(9):799-803. doi: 10.1093/oncolo/oyad128. Oncologist. 2023. PMID: 37226534 Free PMC article. Clinical Trial.
Relapse timing is associated with distinct evolutionary dynamics in DLBCL.
Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JCH, Cruz M, Roth A, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, Freeman CL, Villa D, Crump M, Shepherd L, Hay AE, Kuruvilla J, Savage KJ, Kridel R, Karsan A, Marra MA, Sehn LH, Steidl C, Morin RD, Scott DW. Hilton LK, et al. Among authors: crump m. medRxiv [Preprint]. 2023 Mar 8:2023.03.06.23286584. doi: 10.1101/2023.03.06.23286584. medRxiv. 2023. PMID: 36945587 Free PMC article. Updated. Preprint.
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell Lymphoma.
Vijenthira A, Kuruvilla J, Crump M, Jain M, Prica A. Vijenthira A, et al. Among authors: crump m. J Clin Oncol. 2023 Mar 10;41(8):1577-1589. doi: 10.1200/JCO.22.00478. Epub 2022 Oct 31. J Clin Oncol. 2023. PMID: 36315922
171 results